Search all medical codes
Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
HCPCS code
Name of the Procedure:
Common Name: Andexxa Injection
Technical/Medical Term: Injection, coagulation factor Xa (recombinant), inactivated-zhzo (J7169)
Summary
Andexxa is an injection given to counteract the effects of certain anticoagulant medications that inhibit Factor Xa. It's often used in emergency situations to reverse life-threatening or uncontrolled bleeding.
Purpose
Medical Conditions:
- Emergency reversal of anticoagulation in patients treated with Factor Xa inhibitors. ##### Goals:
- Stop active bleeding
- Prevent further bleeding complications
- Stabilize the patient's condition
Indications
- Major bleeding episodes
- Urgent need for surgery or invasive procedures in patients on Factor Xa inhibitors
- Evidence of severe overdose with Factor Xa inhibitors
Preparation
Pre-Procedure Instructions:
- Inform the healthcare team about all medications and supplements you are taking.
- You may need to fast for a certain period before the procedure. ##### Diagnostic Tests:
- Blood tests to measure coagulation status and effectiveness of anticoagulation therapy.
Procedure Description
- Preparation: Establish an IV line and prepare the appropriate dose of Andexxa based on the patient's coagulation status and body weight.
- Injection: Administer Andexxa through the IV line over a recommended time period.
- Monitoring: Continuous monitoring of vital signs and coagulation parameters during and after the administration.
- Post-Injection Care: Observe for any signs of adverse reactions or complications.
Tools/Equipment
- IV line
- Syringes for the Andexxa injection
- Monitoring devices for vital signs and coagulation status
Anesthesia or Sedation
- Generally not required for this procedure.
Duration
The injection itself typically takes about 30 minutes to administer, but monitoring may extend for several hours.
Setting
- Hospital
- Intensive care unit (ICU)
- Emergency Department
Personnel
- Physicians (e.g. hematologists, emergency medicine specialists)
- Nurses
- Pharmacists
Risks and Complications
Common Risks:
- Infusion-related reactions (e.g., headache, dizziness)
- Nausea
Rare Risks:
- Blood clots
- Cardiac events
- Anaphylaxis
Management:
- Immediate medical intervention for any severe reactions.
- Close monitoring and supportive care for less severe side effects.
Benefits
- Rapid reversal of anticoagulation
- Reduction of bleeding complications
- Ability to undergo urgent surgical procedures safely
Recovery
Post-Procedure Care:
- Continuous monitoring for any adverse effects ##### Recovery Time:
- Varies based on the extent of the bleeding and the patient's overall condition
- Patients may need ongoing monitoring and follow-up appointments
Alternatives
Other Treatment Options:
- Use of blood products (e.g., plasma)
- Protamine sulfate (for heparin reversal, not specific to Factor Xa inhibitors)
Pros and Cons:
- Blood products may not be as quick or specific in reversal.
- Protamine sulfate is not effective against Factor Xa inhibitor-induced anticoagulation.
Patient Experience
- During the procedure, you might feel a slight prick from the IV insertion.
- Post-procedure monitoring ensures you are safe and stable.
- Minimal discomfort is expected, though you may feel fatigued or have mild side effects such as nausea.
- Pain management and comfort measures will be provided as needed.